X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Hok Leong ChinChia-Yi LinOscar Hou-In ChouPublished in: Acta neurologica Belgica (2022)
X-linked dystonia parkinsonism (XDP) is a rare X-linked recessive degenerative movement disorder that only affects Filipino descent, predominantly males. Its underlying cause is associated with the genetic alterations in the TAF1/DYT3 multiple transcription system. SINE-VNTR-Alu (SVA) retrotransposon insertion was suggested to be the responsible genetic mutation. Clinically, it initially presents as focal dystonia and generalizes within years. Parkinsonism arises years later and coexists with dystonia. Nonmotor symptoms like cognitive impairment and mood disorders are also common among XDP patients. XDP diagnosis relies on clinical history and physical examination. On imaging, abnormalities of the striatum, such as atrophy, are widely seen and can explain the clinical presentations with a three-model pathway of the striatum. Treatments aim for symptomatic relief of dystonia and parkinsonism and to prevent complications. Oral medications, chemo-denervation, and surgery are used in XDP patients. This review summarizes the currently important information regarding XDP, providing a synoptic overview and understanding of XDP for future studies.
Keyphrases
- deep brain stimulation
- parkinson disease
- early onset
- end stage renal disease
- ejection fraction
- newly diagnosed
- cognitive impairment
- chronic kidney disease
- prognostic factors
- drug induced
- minimally invasive
- mental health
- physical activity
- radiation therapy
- healthcare
- squamous cell carcinoma
- bipolar disorder
- sleep quality
- intellectual disability
- locally advanced
- photodynamic therapy
- rectal cancer
- percutaneous coronary intervention
- acute coronary syndrome